Rapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection

Journal of Virology

Volumn 70, Issue 10, 1996, Pages 7285-7289

  Ferbas, John ^a,c   Daar, Eric S ^b   Grovit Ferbas, Kathie ^a   Lech, Walter J ^a   Detels, Roger ^a   Giorgi, Janis V ^a   Kaplan, Andrew H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 0029840781     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.10.7285-7289.1996     Document Type: Article

References (34)

1. Abo, T., C. A. Miller, and C. M. Balch. 1984. Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adults. Eur. J. Immunol. 14:616-623.
2. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
3. Centers for Disease Control and Prevention. 1995. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood - France, United Kingdom, and United States, January 1988-August 1994. Morbid. Mortal. Weekly Rep. 44:929-933.
4. Chakrabarti, L., M.-C. Cumont, L. Montagnier, and B. Hurtrel. 1994. Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression. J. Virol. 68:6634-6642.
5. Connor, R. I., and D. D. Ho. 1994. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68:4400-4408.
6. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J. Virol. 67:1772-1777.
7. Cornelissen, M., G. Mulder-Kampinga, J. Veenstra, F. Zorgdrager, C. Kuiken, S. Hartman, J. Dekker, L. van der Hoek, C. Sol, R. Coutinho, and J. Goudsmit. 1995. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J. Virol. 69:1810-1818.
8. Delwart, E. L., H. W. Sheppard, B. D. Walker, J. Goudsmit, and J. I. Mullins. 1994. Human immunodeficiency virus type I evolution in vivo tracked by DNA heteroduplex mobility assays. J. Virol. 68:6672-6683.
9. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Rácz, K. Tenner-Rácz, and A. T. Hasse. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 362:359-362.
10. + lymphocyte activity. J. Infect. Dis. 172:329-339.
11. Giorgi, J. V. Unpublished observation.
12. Giorgi, J. V., H.-L. Cheng, J. B. Margolict, K. D. Bauer, J. Ferbas, M. Waxdal, I. Schmid, L. E. Hultin, A. L. Jackson, L. Park, J. M. G. Taylor, and the Multicenter AIDS Cohort Study. 1990. Quality control in the flow cytometric measurement of T-lymphocyte subsets: the Multicenter AIDS Cohort Study experience. Clin. Immunol. Immunopathol. 55:173-186.
13. + cell levels. J. Infect: Dis. 170:775-781.
14. Henrard, D. R., E. Daar, H. Farzadegan, S. J. Clark, J. Phillips, G. M. Shaw, and M. P. Busch. 1995. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 9:305-310.
15. - cytotoxic T cells express CD38 and HLA-DR antigens. J. Immunol. 150:3070-3079.
16. Karlsson, A., K. Parsmyr, E. Sandström, E. M. Fenyö, and J. Albert. 1994. MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection. J. Clin. Microbiol. 32:364-370.
17. Kaslow, R. A., D. G. Ostrow, R. Detels, J. P. Phair, B. F. Polk, and C. R. Rinaldo, Jr. 1987. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am. J. Epidemiol. 126:310-318.
18. Keet, I. P. M., P. Krijnen, M. Koot, J. M. A. Lange, F. Miedema, J. Goudsmit, and R. A. Coutinho. 1993. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 7:51-57.
19. Kinloch-de Loës, S., B. J. Hirschel, B. Hoen, D. A. Cooper, B. Tindall, A. Carr, J.-H. Saurat, N. Clumeck, A. Lazzarin, L. Mathiesen, F. Raffi, F. Antunes, J. von Overbeck, R. Lüthy, M. Glauser, D. Hawkins, C. Baumberger, S. Yerly, T. V. Perneger, and L. Perrin. 1995. A controlled trial of zidovudine in primary human immunodeficiency virus infection. New Engl. J. Med. 333:408-413.
20. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
21. + T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up. Commun. Clin. Cytometry 26:1-7.
22. Mellors, J. W., L. A. Kingsley, C. R. Rinaldo, Jr., J. A. Todd, B. S. Hoo, R. P. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
23. Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
24. Milich, L., B. Margolin, and R. Swanstrom. 1993. V3 loop of the human immunodeficiency virus type 1 Env protein: Interpreting sequence variability. J. Virol. 67:5623-5634.
25. Moore, J. P., Y. Cao, D. D. Ho, and R. A. Koup. 1994. Development of the anti-gp 120 antibody response during seroconversion to human immunodeficiency virus type 1. J. Virol. 68:5142-5155.
26. Pan, L.-Z., A. Werner, and J. A. Levy. 1993. Detection of plasma viremia in human immunodeficiency virus-infected individuals at all clinical stages. J. Clin. Microbiol. 31:283-288.
27. Pang, S., Y. Shlesinger, E. S. Daar, T. Moudgil, D. D. Ho, and I. S. Y. Chen. 1992. Rapid generation of sequence variation during primary HIV-1 infection. AIDS 6:453-460.
28. Pantaleo, G., C. Graziosi, L. Butini, P. A. Pizzo, S. M. Schnittman, D. P. Kotler, and A. S. Fauci. 1991. Lymphoid organs function as major reservoirs for human immunodeficiency virus (HIV). Proc. Natl. Acad. Sci. USA 88: 9838-9842.
29. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 362:355-358.
30. Sinicco, A., R. Fora, M. Sciandra, A. Lucchini, P. Caramello, and P. Gioannini. 1993. Risk of developing AIDS after primary acute HIV-1 infection. J. Acquired Immune Defic. Syndr. 6:575-581.
31. Tindall, B., and D. A. Cooper. 1991. Primary HIV infection: host responses and intervention strategies. AIDS 5:1-14.
32. Tsai, C. C., K. E. Follis, A. Sabo, T. W. Beck, R. F. Grant, N. Bischolberger, R. E. Benveniste, and R. Black. 1995. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science 270:1197-1199.
33. van't Wout, A. B., N. A. Kootstra, G. A. Mulder-Kampinga, N. Albrecht-van Lent, H. J. Scherpbier, J. Veenstra, K. Boer, R. A. Coutinho, F. Miedema, and H. Schuitemaker. 1994. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J. Clin. Invest. 94:2060-2067.
34. Zhu, T., H. Mo, N. Wang, D. S. Nam, Y. Cao, R. A. Koup, and D. D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:1179-1181.